Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00543_DB01072_nanopub.RAKeJdcnkNZpY4Z5_irkm-63phhGlgJomlziPD-jMFvaE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00543_DB01072 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00543_DB01072 label "DDI between Amoxapine and Atazanavir - Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, amoxapine, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amoxapine if atazanavir if initiated, discontinued or dose changed. [drugbank_resource:DB00543_DB01072]" assertion.
- drugbank_resource:DB00543_DB01072 identifier "drugbank_resource:DB00543_DB01072" assertion.
- drugbank_resource:DB00543_DB01072 title "DDI between Amoxapine and Atazanavir - Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, amoxapine, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amoxapine if atazanavir if initiated, discontinued or dose changed." assertion.
- drugbank:DB01072 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00543_DB01072 assertion.
- drugbank:DB00543 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00543_DB01072 assertion.